eye-3-yellow-3d-2-new-logo philly_kyw_new philly_94wip_new 35h_cbssportsrad_philly philly_wpht_new


FDA Approves Two Companies To Produce Drugs In Short Supply

View Comments
(Photo by Ed Fischer) Lynne Adkins
If you’ve listened to radio in the Delaware Valley, the odds are...
Read More

CBS Philly (con't)

Affordable Care Act Updates: CBSPhilly.com/ACA

Health News & Information: CBSPhilly.com/Health

Get Breaking News First

Receive News, Politics, and Entertainment Headlines Each Morning.
Sign Up

By Lynne Adkins

PHILADELPHIA (CBS) - The FDA has approved additional suppliers for two crucial cancer drugs which have been in short supply for months.

Doctors and Pharmacists have been scrambling for supplies of Methotrexate which is often used to treat leukemia and Doxil a drug for ovarian and other cancers.

Dr. Shayma Kazmi, a medical oncologist at the Cancer Treatment Centers of America in Philadelphia, calls this a good first step.

“I hope they keep continuing this with some of the other medications that are also in shortage and give the field the proper competition so everyone has the incentive to keep the medication in supply.”

Currently more than 280 drugs are in short supply nationwide. Dr. Kazmi expects it to take several months for the additional doses of Doxil and Methotrexate to reach patients.


View Comments

Get every new post delivered to your Inbox.

Join 32,072 other followers